| Literature DB >> 21128088 |
Bart Craane1, Pieter Ubele Dijkstra, Karel Stappaerts, Antoon De Laat.
Abstract
The validity of a systematic review depends on completeness of identifying randomised clinical trials (RCTs) and the quality of the included RCTs. The aim of this study was to analyse the effects of hand search on the number of identified RCTs and of four quality lists on the outcome of quality assessment of RCTs evaluating the effect of physical therapy on temporomandibular disorders. In addition, we investigated the association between publication year and the methodological quality of these RCTs. Cochrane, Medline and Embase databases were searched electronically. The references of the included studies were checked for additional trials. Studies not electronically identified were labelled as "obtained by means of hand search". The included RCTs (69) concerning physical therapy for temporomandibular disorders were assessed using four different quality lists: the Delphi list, the Jadad list, the Megens & Harris list and the Risk of Bias list. The association between the quality scores and the year of publication were calculated. After electronic database search, hand search resulted in an additional 17 RCTs (25%). The mean quality score of the RCTs, expressed as a percentage of the maximum score, was low to moderate and varied from 35.1% for the Delphi list to 54.3% for the Risk of Bias list. The agreement among the four quality assessment lists, calculated by the Interclass Correlation Coefficient, was 0.603 (95% CI, 0.389; 0.749). The Delphi list scored significantly lower than the other lists. The Risk of Bias list scored significantly higher than the Jadad list. A moderate association was found between year of publication and scores on the Delphi list (r = 0.50), the Jadad list (r = 0.33) and the Megens & Harris list (r = 0.43).Entities:
Mesh:
Year: 2010 PMID: 21128088 PMCID: PMC3259329 DOI: 10.1007/s00784-010-0490-y
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.573
Overview of four quality lists: Delphi, Risk of Bias (RoB), Megens and Harris (M&H) and Jadad
| Delphi | RoB | M&H | Jadad |
|---|---|---|---|
|
| |||
| Was the method of randomisation performed | Was the allocation sequence adequately generated? | Was the study randomised (this includes the use of words such as randomly, random and randomisation)? | Was the study described as randomised (this includes the use of words such as randomly, random and randomisation)? |
| +1 Described | +1 Described and appropriate | ||
| −1 Described and inappropriate | |||
| If subjects were randomly allocated to treatment groups, was the method of random allocation concealed? | Was the allocation adequately concealed? | ||
|
| |||
| Were the groups similar at baseline regarding the most important prognostic characteristics? | Were the groups similar at baseline? | ||
|
| |||
| Were both inclusion and exclusion criteria specified? | Were the inclusion and exclusion criteria listed for the subjects? | ||
|
| |||
| Was the outcome assessor blinded? | Was knowledge of the allocated interventions adequately prevented during the study? | Was the patient, the treatment provider and the assessor blinded? | Was the study described as double blind? (blinding of patients and evaluators, not necessarily therapist) |
| Was the patient blinded? | +1 Method of blinding described and appropriate | ||
| Was the care provider blinded? | −1 Method of blinding not appropriate | ||
|
| |||
| Were point estimates and measures of variability presented for primary outcome measure(s)? | |||
| Did the analysis include an ‘intention-to-treat’ analysis? | |||
| Drop-outs and completeness data | |||
| Were the drop-outs described and acceptable? | Were incomplete outcome data adequately addressed? | Were the drop outs reported? | Was there a description of withdrawals and drop-outs? (explicit statement that all included patients were analysed or if the number and reasons for dropouts in all groups are given separately) |
|
| |||
| Was the treatment protocol sufficiently described to be replicable? | |||
| Was the validity of data obtained with the outcome measures addressed? | |||
| Was the reliability of data obtained with the outcome measures investigated? | |||
| Was the follow-up minimum 6 months? | |||
| Was a home program adherence investigated? If included! | |||
| Are reports of the study free of suggestion of selective outcome reporting? | |||
| Was the study apparently free of other problems that could put it at a risk of bias? | |||
Fig. 1Number of RCTs according to the source of identification (Cochrane = the Cochrane Central Register of Controlled Trials)
Results of the quality score for the different criteria lists expressed as a percentage of the maximum possible positive items scored
| Author | Delphi (%) | RoB (%) | M&H (%) | Jadad (%) |
|---|---|---|---|---|
| Al-Badawi 2004 | 40 | 67 | 40 | 40 |
| Alvaraz 2002 | 10 | 33 | 20 | 20 |
| Bakke 2008 | 40 | 33 | 60 | 40 |
| Bender 1991 | 20 | 33 | 30 | 20 |
| Bertolucci 1995 | 20 | 33 | 30 | 20 |
| Brooke 1983 | 10 | 50 | 30 | 40 |
| Burgess 1988 | 30 | 50 | 40 | 40 |
| Carlson 2001 | 60 | 67 | 64 | 80 |
| Carmeli 2001 | 30 | 50 | 50 | 60 |
| Conti 1997 | 40 | 50 | 50 | 60 |
| Crockett 1986 | 20 | 33 | 36 | 20 |
| Dahlstrom 1984 | 0 | 50 | 27 | 40 |
| Dalen 1986 | 10 | 0 | 27 | 20 |
| De Abreu 2005 | 40 | 67 | 50 | 60 |
| DeLaat 2003 | 40 | 67 | 60 | 60 |
| Dogu 2009 | 20 | 50 | 40 | 20 |
| Dohrman 1978 | 30 | 50 | 36 | 60 |
| Dworkin 1994 | 60 | 83 | 73 | 80 |
| Dworkin 2002a | 40 | 50 | 64 | 40 |
| Dworkin 2002b | 40 | 50 | 36 | 40 |
| Erlandson 1989 | 10 | 50 | 30 | 40 |
| Funch 1984 | 30 | 33 | 73 | 60 |
| Gardea 2001 | 60 | 67 | 70 | 60 |
| Gavish 2006 | 40 | 67 | 60 | 60 |
| Glaros 2007 | 50 | 67 | 64 | 60 |
| Glas 2000 | 30 | 67 | 46 | 60 |
| Gray 1994 | 30 | 33 | 40 | 80 |
| Ismaïl 2007 | 50 | 50 | 30 | 40 |
| Kavuncu 1999 | 20 | 50 | 30 | 40 |
| Klobas 2006 | 40 | 100 | 73 | 80 |
| Komiyama 1999 | 30 | 50 | 60 | 40 |
| Kopp 1979 | 20 | 67 | 30 | 60 |
| Kruger 1998 | 20 | 33 | 30 | 20 |
| Kulekcioglu 2003 | 40 | 50 | 50 | 40 |
| Linde 1985 | 30 | 50 | 36 | 40 |
| Magnussen 1999 | 20 | 0 | 46 | 40 |
| Maloney 2002 | 20 | 33 | 40 | 20 |
| Mazzetto 2007 | 40 | 50 | 50 | 80 |
| Michelotti 2004 | 50 | 50 | 64 | 40 |
| Minakuchi 2004 | 70 | 83 | 70 | 80 |
| Monteiro 1988 | 0 | 33 | 18 | 20 |
| Moystad 1990 | 40 | 50 | 50 | 40 |
| Mulet 2007 | 60 | 83 | 82 | 80 |
| Nunez 2006 | 30 | 50 | 40 | 40 |
| Okeson 1983 | 20 | 50 | 36 | 40 |
| Olson 1987 | 20 | 67 | 40 | 60 |
| Peroz 2004 | 80 | 100 | 70 | 80 |
| Reid 1994 | 50 | 50 | 60 | 60 |
| Schiffman 1996 | 60 | 67 | 60 | 60 |
| Schiffman 2007 | 70 | 100 | 100 | 80 |
| Shin 1997 | 30 | 50 | 40 | 40 |
| Stam 1984 | 30 | 67 | 60 | 40 |
| Stegenga 1993 | 20 | 50 | 50 | 40 |
| Stenn 1979 | 30 | 33 | 30 | 40 |
| Talaat 1986 | 0 | 33 | 20 | 20 |
| Taube 1988 | 30 | 67 | 40 | 60 |
| Taylor 1987 | 50 | 67 | 40 | 60 |
| Taylor 1994 | 40 | 50 | 40 | 40 |
| Townsend 2001 | 20 | 50 | 70 | 20 |
| Treacy 1999 | 30 | 67 | 50 | 40 |
| Truelove 2006 | 70 | 83 | 82 | 80 |
| Tullberg 2003 | 70 | 83 | 60 | 80 |
| Turk 1993 | 20 | 33 | 27 | 40 |
| Turner 2008 | 70 | 83 | 90 | 60 |
| Wahlund 2003 | 30 | 67 | 64 | 60 |
| Wright 1995 | 50 | 50 | 80 | 60 |
| Wright 2000 | 50 | 67 | 73 | 60 |
| Yuasa 2001 | 10 | 17 | 30 | 0 |
| Yoshida 2005 | 40 | 67 | 60 | 60 |
The mean quality scores (+standard error) expressed as a percentage of the maximum possible score
| Scale | Mean score | Std. error | 95% Confidence interval |
|---|---|---|---|
| Delphi | 35.1 | 2.2 | 30.6; 39.5 |
| Risk of bias | 54.3 | 2.4 | 49.5; 59.2 |
| MH | 49.5 | 2.2 | 45.1; 53.9 |
| Jadad | 48.7 | 2.4 | 43.9; 53.5 |